Baku 19° C
Azerbaijan starts applying AstraZeneca vaccine
Health
- 03 May, 2021
- 04:54
Add Report.az to preferred Google sources
Stay up to date with the top news!
From May 3, Azerbaijan begins using the Vaxzevria vaccine produced by the University of Oxford (AstraZeneca manufacturer name) for vaccination against COVID-19 in the country (at the preliminary stage for people aged 60 and over), Report informs.
Vaxzevria vaccines will be used in the city of Baku and six regions - Lankaran, Sheki, Ganja, Mingachevir, Absheron and Sumgait.
The 84,000 doses of Vaxzevria vaccines delivered to Azerbaijan through the COVAX platform increase the possibility of choice for citizens and at the same time enhance the availability of vaccines for the population.
The Vaxzevria vaccine, developed by the Anglo-Swedish company AstraZeneca, was approved by the World Health Organization.
Author
Azərbaycanda “AstraZeneca” peyvəndinin tətbiqinə başlanılır
В Азербайджане начинается применение вакцины AstraZeneca
Latest News
16:57
Aynur Sofiyeva: Women account for more than 48% of Azerbaijan's employed population
Domestic policy
16:43
Appcharge registers for tax purposes in Azerbaijan
Business
16:34
Nearly 140 illegal migrants rescued off Spain's Lanzarote island
Other countries
16:18
Mirziyoyev outlines changes to Uzbekistan's labor migration system
Other countries
16:12
Chamber of Accounts presents its assessment of Azerbaijan's draft budget for 2027
Finance
16:04
Georgian PM urges more effective diplomacy to address external challenges
Region
15:57
Hackers raised freezer temperature at Estonian supermarket chain to +50°C
Other countries
15:38
European Commission to hold dialogue on Middle Corridor competitiveness
Infrastructure
15:36
Telegram leads for news in Uzbekistan, but TV retains most trust, survey finds
Other countries